Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,684 public trials 799 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00025285

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • CCOP - Central Illinois Decatur, Illinois, United States
  • Southeastern Medical Oncology Center Goldsboro, North Carolina, United States
  • Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States
  • CCOP - Greenville Greenville, South Carolina, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00025272

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Southeastern Medical Oncology Center Goldsboro, North Carolina, United States
  • Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States
  • CCOP - Greenville Greenville, South Carolina, United States
  • CCOP - Upstate Carolina Spartanburg, South Carolina, United States
View Trial Details
Completed

Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT00004202

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Completed

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

NCT02737501

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +17 more
Locations
  • USOR - Arizona Oncology Associates - Sedona Sedona, Arizona, United States
  • Kaiser Permanente Bellflower Medical Offices Bellflower, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers - Boulder Boulder, Colorado, United States
View all 91 locations
View Trial Details

Related conditions